Reason: Rebranded as Elevance Health
Last recorded trade on: April 29, 2022
Source: https://www.fiercehealthcare.com/payers/anthem-unveils-corporate-rebrand-elevance-health
P/E ratio for Anthem (ANTM)
P/E ratio on April 29, 2022 (TTM): 18.8
According to Anthem's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 18.7681. At the end of 2021 the company had a P/E ratio of 18.5.
P/E ratio history for Anthem from 2002 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 18.5 | 4.83% |
| 2020 | 17.7 | 10.03% |
| 2019 | 16.1 | |
| 2017 | 15.2 | -0.4% |
| 2016 | 15.3 | 6.74% |
| 2015 | 14.3 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 18.3 | -2.52% | 🇺🇸 USA |
 | 23.0 | 22.36% | 🇺🇸 USA |
 | 14.0 | -25.38% | 🇺🇸 USA |
 | 10.6 | -43.53% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.